L-carnitine administration reduces number of episodes in cyclic vomiting syndrome.
Patients with cyclic vomiting syndrome suffer from recurring episodes of severe nausea and vomiting. This paper presents 6 patients who responded to 1-carnitine administration. Average time between episodes was 1.7 months before carnitine administration and increased to 1.1 years after carnitine administration. Average dose of carnitine administered was 50 mg/kg. Oral carnitine may be useful to control the symptoms in patients with cyclic vomiting syndrome.
Van Calcar
Sandra C
SC
Biochemical Genetics Program, Waisman Center, University of Wisconsin-Madison, USA.
Harding
Cary O
CO
Wolff
Jon A
JA
D000293:Adolescent; D002331:Carnitine / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D013997:Time Factors; D014839:Vomiting / Q000188:drug therapy* / Q000503:physiopathology
D002331:Carnitine